1
|
Liu H, Liang Y, Wang C, Li D, Yan X, Nan CW, Fan LZ. Priority and Prospect of Sulfide-Based Solid-Electrolyte Membrane. Adv Mater 2022:e2206013. [PMID: 35984755 DOI: 10.1002/adma.202206013] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/02/2022] [Revised: 08/06/2022] [Indexed: 06/15/2023]
Abstract
All-solid-state lithium batteries (ASSLBs) employing sulfide solid electrolytes (SEs) promise sustainable energy storage systems with energy-dense integration and critical intrinsic safety, yet they still require cost-effective manufacturing and the integration of thin membrane-based SE separators into large-format cells to achieve scalable deployment. This review, based on an overview of sulfide SE materials, is expounded on why implementing a thin membrane-based separator is the priority for mass production of ASSLBs and critical criteria for capturing a high-quality thin sulfide SE membrane are identified. Moreover, from the aspects of material availability, membrane processing, and cell integration, the major challenges and associated strategies are described to meet these criteria throughout the whole manufacturing chain to provide a realistic assessment of the current status of sulfide SE membranes. Finally, future directions and prospects for scalable and manufacturable sulfide SE membranes for ASSLBs are presented.
Collapse
Affiliation(s)
- Hong Liu
- Beijing Advanced Innovation Center for Materials Genome Engineering, Beijing Key Laboratory for Advanced Energy Materials and Technologies, University of Science and Technology Beijing, Beijing, 100083, China
| | - Yuhao Liang
- Beijing Advanced Innovation Center for Materials Genome Engineering, Beijing Key Laboratory for Advanced Energy Materials and Technologies, University of Science and Technology Beijing, Beijing, 100083, China
| | - Chao Wang
- Beijing Advanced Innovation Center for Materials Genome Engineering, Beijing Key Laboratory for Advanced Energy Materials and Technologies, University of Science and Technology Beijing, Beijing, 100083, China
| | - Dabing Li
- Beijing Advanced Innovation Center for Materials Genome Engineering, Beijing Key Laboratory for Advanced Energy Materials and Technologies, University of Science and Technology Beijing, Beijing, 100083, China
| | - Xiaoqin Yan
- The Beijing Municipal Key Laboratory of New Energy Materials and Technologies, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, 100083, China
| | - Ce-Wen Nan
- State Key Laboratory of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing, 100084, China
| | - Li-Zhen Fan
- Beijing Advanced Innovation Center for Materials Genome Engineering, Beijing Key Laboratory for Advanced Energy Materials and Technologies, University of Science and Technology Beijing, Beijing, 100083, China
| |
Collapse
|
2
|
Waloschková E, Gonzalez-Ramos A, Mikroulis A, Kudláček J, Andersson M, Ledri M, Kokaia M. Human Stem Cell-Derived GABAergic Interneurons Establish Efferent Synapses onto Host Neurons in Rat Epileptic Hippocampus and Inhibit Spontaneous Recurrent Seizures. Int J Mol Sci 2021; 22:ijms222413243. [PMID: 34948040 PMCID: PMC8705828 DOI: 10.3390/ijms222413243] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Revised: 12/03/2021] [Accepted: 12/05/2021] [Indexed: 11/17/2022] Open
Abstract
Epilepsy is a complex disorder affecting the central nervous system and is characterised by spontaneously recurring seizures (SRSs). Epileptic patients undergo symptomatic pharmacological treatments, however, in 30% of cases, they are ineffective, mostly in patients with temporal lobe epilepsy. Therefore, there is a need for developing novel treatment strategies. Transplantation of cells releasing γ-aminobutyric acid (GABA) could be used to counteract the imbalance between excitation and inhibition within epileptic neuronal networks. We generated GABAergic interneuron precursors from human embryonic stem cells (hESCs) and grafted them in the hippocampi of rats developing chronic SRSs after kainic acid-induced status epilepticus. Using whole-cell patch-clamp recordings, we characterised the maturation of the grafted cells into functional GABAergic interneurons in the host brain, and we confirmed the presence of functional inhibitory synaptic connections from grafted cells onto the host neurons. Moreover, optogenetic stimulation of grafted hESC-derived interneurons reduced the rate of epileptiform discharges in vitro. We also observed decreased SRS frequency and total time spent in SRSs in these animals in vivo as compared to non-grafted controls. These data represent a proof-of-concept that hESC-derived GABAergic neurons can exert a therapeutic effect on epileptic animals presumably through establishing inhibitory synapses with host neurons.
Collapse
Affiliation(s)
- Eliška Waloschková
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
- Correspondence: (E.W.); (M.K.)
| | - Ana Gonzalez-Ramos
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
| | - Apostolos Mikroulis
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
| | - Jan Kudláček
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
- Department of Physiology, Second Faculty of Medicine, Charles University, 150 06 Prague, Czech Republic
| | - My Andersson
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
| | - Marco Ledri
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
| | - Merab Kokaia
- Epilepsy Center, Department of Clinical Sciences, Lund University Hospital, 221 84 Lund, Sweden; (A.G.-R.); (A.M.); (J.K.); (M.A.); (M.L.)
- Correspondence: (E.W.); (M.K.)
| |
Collapse
|
3
|
Reshamwala R, Shah M, St John J, Ekberg J. Survival and Integration of Transplanted Olfactory Ensheathing Cells are Crucial for Spinal Cord Injury Repair: Insights from the Last 10 Years of Animal Model Studies. Cell Transplant 2019; 28:132S-159S. [PMID: 31726863 PMCID: PMC7016467 DOI: 10.1177/0963689719883823] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Olfactory ensheathing cells (OECs), the glial cells of the primary olfactory nervous system, support the natural regeneration of the olfactory nerve that occurs throughout life. OECs thus exhibit unique properties supporting neuronal survival and growth. Transplantation of OECs is emerging as a promising treatment for spinal cord injury; however, outcomes in both animals and humans are variable and the method needs improvement and standardization. A major reason for the discrepancy in functional outcomes is the variability in survival and integration of the transplanted cells, key factors for successful spinal cord regeneration. Here, we review the outcomes of OEC transplantation in rodent models over the last 10 years, with a focus on survival and integration of the transplanted cells. We identify the key factors influencing OEC survival: injury type, source of transplanted cells, co-transplantation with other cell types, number and concentration of cells, method of delivery, and time of transplantation after the injury. We found that two key issues are hampering optimization and standardization of OEC transplantation: lack of (1) reliable methods for identifying transplanted cells, and (2) three-dimensional systems for OEC delivery. To develop OEC transplantation as a successful and standardized therapy for spinal cord injury, we must address these issues and increase our understanding of the complex parameters influencing OEC survival.
Collapse
Affiliation(s)
- Ronak Reshamwala
- Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.,Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.,Clem Jones Centre for Neurobiology and Stem Cell Research, Griffith University, Brisbane, Queensland, Australia
| | - Megha Shah
- Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.,Clem Jones Centre for Neurobiology and Stem Cell Research, Griffith University, Brisbane, Queensland, Australia
| | - James St John
- Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.,Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.,Clem Jones Centre for Neurobiology and Stem Cell Research, Griffith University, Brisbane, Queensland, Australia
| | - Jenny Ekberg
- Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.,Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.,Clem Jones Centre for Neurobiology and Stem Cell Research, Griffith University, Brisbane, Queensland, Australia
| |
Collapse
|
4
|
Abboud N, Fontbonne A, Watabe I, Tonetto A, Brezun JM, Feron F, Zine A. Culture conditions have an impact on the maturation of traceable, transplantable mouse embryonic stem cell-derived otic progenitor cells. J Tissue Eng Regen Med 2016; 11:2629-2642. [PMID: 27099197 DOI: 10.1002/term.2163] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Revised: 12/29/2015] [Accepted: 02/03/2016] [Indexed: 01/02/2023]
Abstract
The generation of replacement inner ear hair cells (HCs) remains a challenge and stem cell therapy holds the potential for developing therapeutic solutions to hearing and balance disorders. Recent developments have made significant strides in producing mouse otic progenitors using cell culture techniques to initiate HC differentiation. However, no consensus has been reached as to efficiency and therefore current methods remain unsatisfactory. In order to address these issues, we compare the generation of otic and HC progenitors from embryonic stem (ES) cells in two cell culture systems: suspension vs. adherent conditions. In the present study, an ES cell line derived from an Atoh1-green fluorescent protein (GFP) transgenic mouse was used to track the generation of otic progenitors, initial HCs and to compare these two differentiation systems. We used a two-step short-term differentiation method involving an induction period of 5 days during which ES cells were cultured in the presence of Wnt/transforming growth factor TGF-β inhibitors and insulin-like growth factor IGF-1 to suppress mesoderm and reinforce presumptive ectoderm and otic lineages. The generated embryoid bodies were then differentiated in medium containing basic fibroblast growth factor (bFGF) for an additional 5 days using either suspension or adherent culture methods. Upon completion of differentiation, quantitative polymerase chain reaction analysis and immunostaining monitored the expression of otic/HC progenitor lineage markers. The results indicate that cells differentiated in suspension cultures produced cells expressing otic progenitor/HC markers at a higher efficiency compared with the production of these cell types within adherent cultures. Furthermore, we demonstrated that a fraction of these cells can incorporate into ototoxin-injured mouse postnatal cochlea explants and express MYO7A after transplantation. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Nesrine Abboud
- Aix-Marseille Université, LNIA, CNRS, UMR 7260, Marseille, France
| | - Arnaud Fontbonne
- Aix-Marseille Université, LNIA, CNRS, UMR 7260, Marseille, France
| | - Isabelle Watabe
- Aix-Marseille Université, LNIA, CNRS, UMR 7260, Marseille, France
| | - Alain Tonetto
- Pôle PRATIM, Fédération de Chimie de Marseille. Aix-Marseille Université, Marseille, France
| | | | - François Feron
- Aix-Marseille Université, NICN, CNRS, UMR 7259, Marseille, France
| | - Azel Zine
- Aix-Marseille Université, LNIA, CNRS, UMR 7260, Marseille, France.,Laboratoire de Biophysique, Faculté de Pharmacie, Université de Montpellier, Montpellier, France
| |
Collapse
|
5
|
Haddad-Mashadrizeh A, Bahrami AR, Matin MM, Edalatmanesh MA, Zomorodipour A, Gardaneh M, Farshchian M, Momeni-Moghaddam M. Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation. Xenotransplantation 2013; 20:165-76. [PMID: 23679842 DOI: 10.1111/xen.12033] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2012] [Accepted: 03/18/2013] [Indexed: 12/17/2022]
Abstract
BACKGROUND Novel threads of discovery provide the basis for optimism for the development of a stem-cell-based strategy for the treatment of retinal blindness. Accordingly, achievement to suitable cell source with potential-to-long-term survival and appropriate differentiation can be an effective step in this direction. METHODS After derivation of human adipose-derived mesenchymal stem cells (HAD-MSCs), they were stably transfected with a vector containing Turbo-green fluorescent protein (GFP) and JRed to be able to trace them after transplantation. Labeled HAD-MSCs were transplanted into the intact adult rat eye and their survival, integration, and migration during 6 months post-transplantation were assessed. RESULTS The transplanted cells were traceable in the rat vitreous humor (VH) up until 90 days after transplantation, with gradual reduction in numbers, their adhesion and expansion capacity after recovery. These cells were also integrated into the ocular tissues. Nonetheless, some of the implanted cells succeeded to cross the blood-retina barrier (BRB) and accumulate in the spleen with time. CONCLUSIONS The survival of the HAD-MSCs for a period of 90 days in VH and even longer period of up to 6 months in other eye tissues makes them a promising source to be considered in regenerative medicine of eye diseases. However, the potency of crossing the BRB by the implanted cells suggests that use of HAD-MSCs must be handled with extreme caution.
Collapse
Affiliation(s)
- Aliakbar Haddad-Mashadrizeh
- Cell and Molecular Biotechnology Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran; Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
| | | | | | | | | | | | | | | |
Collapse
|